Metabolic and Weight Management Research
Compounds studied for adipose tissue metabolism, insulin sensitivity, appetite regulation, and growth hormone secretagogue activity
Metabolic research covers a broad range of biological mechanisms related to energy balance, adipose tissue regulation, glucose homeostasis, and the endocrine axes that govern body composition. Compounds in this area are studied across multiple mechanistic layers, including direct lipolysis stimulation, GLP-1 receptor-mediated appetite suppression, AMPK-driven metabolic flexibility, NAD+-dependent mitochondrial regulation, and GH-axis-driven body composition effects. Each compound targets a distinct point in the metabolic regulation network, making comparative evaluation relevant for researchers designing complex metabolic models or studying obesity and metabolic syndrome in preclinical systems.
Compounds in This Use Case
Each compound contributes a distinct mechanism relevant to this research objective.
GLP-1 (Sema)
$179Role
GLP-1 receptor agonist studied for glucose-dependent insulin secretion, appetite suppression via hypothalamic signaling, and gastric emptying delay.
Mechanism
Activates GLP-1 receptors on pancreatic beta cells to enhance insulin secretion in a glucose-dependent manner, and acts on hypothalamic and brainstem GLP-1 receptors to suppress appetite and extend satiety.
MOTS-c
$149Role
Mitochondrial-derived peptide studied for AMPK activation, skeletal muscle insulin sensitivity, and anti-obesity effects in animal models.
Mechanism
Activates AMPK via retrograde mitochondrial signaling, promoting skeletal muscle glucose uptake, mitochondrial fatty acid oxidation, and metabolic flexibility, with documented reductions in adiposity in mouse studies.
AOD-9604
$99Role
HGH C-terminal fragment studied for adipose-specific lipolysis stimulation without affecting IGF-1 or insulin levels.
Mechanism
Represents residues 176 to 191 of human growth hormone and stimulates lipolysis in adipose tissue via beta-3 adrenergic receptor interactions, without the IGF-1-elevating or diabetogenic effects associated with full HGH.
NAD+
$279Role
Coenzyme studied for mitochondrial biogenesis, sirtuin-mediated metabolic gene regulation, and cellular energy metabolism in aging models.
Mechanism
Supports SIRT1 and SIRT3 activation and PGC-1alpha-driven mitochondrial biogenesis, improving metabolic gene expression and oxidative capacity in muscle and metabolic tissues.
Tesamorelin
$159Role
Full-length GHRH analog studied for visceral adipose tissue reduction and physiological GH secretion stimulation.
Mechanism
Activates the GHRH receptor to stimulate pituitary GH release in a manner that preserves somatostatin-mediated negative feedback, producing visceral fat reduction as documented in HIV lipodystrophy clinical trials (FDA-approved as Egrifta).
Research Context
Metabolic research compounds are among the most clinically-adjacent in the peptide research landscape. GLP-1 receptor agonists have multiple FDA-approved drugs as reference comparators, and Tesamorelin itself is FDA-approved for HIV lipodystrophy. MOTS-c was identified only in 2015 but has rapidly become a subject of metabolic aging research given its mitochondrial origin and AMPK mechanism. AOD-9604 completed Phase 2a human trials for obesity in the early 2000s. The combination of these compounds allows researchers to study metabolic disease across several mechanistic levels simultaneously.
Related Compound Comparisons
Explore side-by-side mechanism comparisons for the compounds in this use case.
Frequently Asked Questions
Source These Compounds
All compounds in this use case are available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.